Press Release 04.25.2025
Science & Innovation 04.24.2025
Amgen's DNA encoded library platform helps researchers screen billions of compounds to fuel the search for new small molecule therapies.
Science & Innovation 04.17.2025
An Amgen-developed machine learning model, ATOMIC, is accelerating clinical trials to bring medicines to patients more quickly.
Science & Innovation 04.09.2025
Cutting-edge omics research provides deep insights into the underlying cause of disease.
Science & Innovation 04.08.2025
How one of the first biotech companies grew into a global leader by taking on the world's toughest diseases.
Science & Innovation 04.03.2025
PRESS RELEASE
Amgen is a pioneer in the science of using living cells to make biologic medicines.
Amgen’s medicines treat serious illnesses and typically address diseases with a limited number of treatment options.
Making a positive difference in the world is at the heart of what we do at Amgen—and it goes beyond making vital medicines.
Amgen is a pioneer in the science of using living cells to make biologic medicines, leading and guiding the biotech industry.
Encounter opportunities both new and undiscovered, as we embrace leading-edge technologies, invest in our talents, and maximize our potential.
